Vanda Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $533.5M
Liabilities Breakdown FY2020
Total Liabilities: $80.2M
Asset Breakdown
Total Assets: $533.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $61.0M | 11.4% |
| Accounts Receivable | $30.0M | 5.6% |
| Inventory | $1.3M | 0.2% |
| Property, Plant & Equipment | $4.1M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $21.6M | 4.0% |
| Other Assets | $415.4M | 77.9% |
Liabilities Breakdown
Total Liabilities: $80.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $80.2M | 100.0% |